New post-hoc analysis shows negative symptoms and stimulant use were the strongest predictors of positive response to adjunctive xanomeline-trospium (Cobenfy). In the data of inpatient add-on administration of Cobenfy, presence of intellectual…
New post-hoc analysis shows negative symptoms and stimulant use were the strongest predictors of positive response to adjunctive xanomeline-trospium (Cobenfy). In the data of inpatient add-on administration of Cobenfy, presence of intellectual…